Wall Street dips with Intel, investors consider Trump's preferred Fed chair report

The S&P 500 and Dow eased while the Nasdaq achieved a record closing high, reflecting a mixed market influenced by specific corporate news and evolving trade policy. Eli Lilly shares plunged 14.1% on disappointing oral weight loss drug data, and Fortinet dropped 22% due to a weak revenue forecast, weighing on the broader indices. This was partially offset by Apple's 3.2% gain, benefiting from tariff exemptions as new, higher U.S. import duties took effect. Concurrently, President Trump nominated Stephen Miran to the Federal Reserve Board, while market expectations for a September rate cut remained robust.

Analysis

The U.S. equity market exhibited significant divergence, with the Dow and S&P 500 declining while the Nasdaq Composite reached a new record high, driven by company-specific catalysts rather than broad market sentiment. Major detractors included Eli Lilly (LLY), which fell 14.1% after disappointing data from its oral weight loss drug trial overshadowed an increased full-year profit and sales forecast. Similarly, cybersecurity firm Fortinet (FTNT) plunged 22% on a weaker-than-expected revenue forecast. Geopolitical factors also weighed on sentiment, as Intel (INTC) dropped 3.1% after the U.S. President called for its CEO's resignation. Counterbalancing these losses, Apple (AAPL) surged 3.2%, lifting the Nasdaq after receiving exemptions from new 100% tariffs on semiconductors for firms with U.S. manufacturing commitments. This occurred as broader tariffs raised the average U.S. import duty to a century-high, and market breadth was negative, with declining issues outnumbering advancers. Despite a minor increase in weekly jobless claims, futures markets continue to price in a 93.2% probability of a September Fed rate cut, a factor providing underlying support amidst the crosscurrents.

Key Decisions for Investors

• Given the significant performance dispersion, prioritize stock-specific fundamentals and catalysts over broad index exposure, as demonstrated by the sharp, divergent moves in Eli Lilly and Apple.
• Investors should closely monitor political and trade policy developments, as presidential statements and tariff exemptions are creating material single-stock volatility for companies like Intel and Apple.
• Exercise caution with high-valuation growth stocks, as Eli Lilly's sharp decline on a pipeline update, despite a raised annual forecast, indicates the market's low tolerance for any disruption to future growth narratives.
• While high odds of a Fed rate cut provide a tailwind, note the weak market breadth and analyst commentary of a 'tired' rally as potential signs of vulnerability to macroeconomic headwinds like the newly enacted tariffs.